Alzai Health Corp. (TSXV:ALZI)
Canada · Delayed Price · Currency is CAD 0.3550
0.00 (0.00%)
Aug 6, 2026, 10:33 AM EST
Alzai Health Statistics
Total Valuation
Alzai Health has a market cap or net worth of CAD 22.77 million. The enterprise value is 22.56 million.
| Market Cap | 22.77M |
| Enterprise Value | 22.56M |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Alzai Health has 64.15 million shares outstanding.
| Current Share Class | 64.15M |
| Shares Outstanding | 64.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +3.22% |
| Owned by Insiders (%) | 13.87% |
| Owned by Institutions (%) | n/a |
| Float | 55.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 99.60 |
| P/TBV Ratio | 180.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60
| Current Ratio | 1.60 |
| Quick Ratio | 1.55 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -645.32% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.69 |
| Average Volume (20 Days) | 27,208 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -38,260 |
| Operating Income | -1.48M |
| Pretax Income | -1.50M |
| Net Income | -1.50M |
| EBITDA | n/a |
| EBIT | -1.48M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 313,370 in cash and no debt, with a net cash position of 313,370 or 0.00 per share.
| Cash & Cash Equivalents | 313,370 |
| Total Debt | n/a |
| Net Cash | 313,370 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 228,648 |
| Book Value Per Share | 0.01 |
| Working Capital | 125,874 |
Cash Flow
| Operating Cash Flow | -1.10M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Alzai Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |